Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-14
2011-06-14
Saeed, Kamal A (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S361100, C514S406000, C514S407000
Reexamination Certificate
active
07960563
ABSTRACT:
The present invention relates to novel indazole derivatives having pharmacological activity, processes for their preparation, compositions containing them and uses of these compounds in the treatment of estrogen receptor beta mediated diseases.
REFERENCES:
patent: 6407261 (2002-06-01), Anderson et al.
patent: 2004/0138286 (2004-07-01), Imazaki et al.
patent: 2005/0153941 (2005-07-01), Miyabayashi et al.
patent: 07070078 (1995-03-01), None
patent: WO 9318008 (1993-09-01), None
patent: 2006040351 (2006-04-01), None
patent: WO 2006040351 (2006-04-01), None
patent: 2007046747 (2007-04-01), None
Liu et al. Journal of Organic Chemistry (2008), 73(1), 219-226.
Mosti, Luisa et al.; 4-substituted 1-phenyl-1H-indazoles with analgesic, antiinflammatory, antipyretic and local anestheic activites; II Farmaco; 1990; 45(4); 415-429; Italy.
Johnson Christopher Norbert
Jones David G
Liang Xi
MacPherson David Timothy
Miller Aaron B
Glaxo Group Limited
Grazier Nyeemah
Saeed Kamal A
Young J. Scott
LandOfFree
Indazoles used to treat estrogen receptor beta mediated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indazoles used to treat estrogen receptor beta mediated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazoles used to treat estrogen receptor beta mediated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2643050